Human papillomavirus vaccine market is anticipated to grow at a significant CAGR of 7.1% during the forecast period. The rising prevalence of HPV-related malignancies of the anus, vulva, vagina, penile, and oropharynx, along with the growing demand for prevention of these infections, are the driving factors supporting the growth of the forecast period. Additionally, during the forecast period, government initiatives for HPV vaccination programs are expected to enhance the market growth. For instance, in June 2020, around 55% of WHO member states had implemented HPV vaccination. Furthermore, rising healthcare infrastructure and spending in emerging countries are likely to open up human papillomavirus vaccine market prospects. However, government rules governing the manufacture of new vaccines, on the other hand, are expected to stifle market expansion.
The COVID-19 pandemic had a significant impact on the global human papillomavirus vaccine market, disrupting many critical health services, including routine immunization procedures. Transportation disruptions, health personnel being unavailable due to safety and health concerns, and also due to a shortage of personal protective equipment, are all contributing causes. People have been hesitant to leave their homes to get immunized due to restrictions on movement or fear of being exposed to people who have COVID-19. All these factors have contributed to the decline in the growth of the market.
To Request a Sample of our Report on Human Papillomavirus Vaccine Market: https://www.omrglobal.com/request-sample/human-papillomavirus-vaccine-hpv-market
Human Papillomavirus Vaccine Market Segmentation
By Type
- Bivalent
- Quadrivalent
- Nonavalent
By Indication
- Cervical Cancer
- Anal Cancer
- Penile Cancer
- Vaginal Cancer
- Oropharyngeal Cancer
- Genital Warts
- Others
A full Report of Global Human Papillomavirus Vaccine Market is Available @ https://www.omrglobal.com/industry-reports/human-papillomavirus-vaccine-hpv-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- A-S Medical Solutions LLC
- AstraZeneca PLC
- Bavarian Nordic A/S
- Bharat Biotech Ltd.
- GlaxoSmithKline PLC
- Innovax Pharmaceutical LLP
- Inovio Pharmaceuticals Inc.
- Johnson & Johnson Services Ltd.
- Merck & Co. Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/human-papillomavirus-vaccine-hpv-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
